Status:
UNKNOWN
Effect of Sea Weed (Ecklonia Cava Extract) on Blood Glucose and Insulin Level on Pre-diabetic Patients
Lead Sponsor:
King Saud University
Collaborating Sponsors:
Dr. Khalid ALdybayan
Ms. Haneen Molla
Conditions:
PreDiabetes
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Introduction: The inhibition of α-amylase and α-glucosidase enzymes is suggested strategy for glycemic control particularly in people with prediabetes and diabetes. Polyphenola-rich brown seaweed ext...
Detailed Description
Methods: Study design: Double-blind, Randomized-controlled trial that will be conducted from 1st March 2021 to 20th July 2021 in Saudi Arabia. Application of ethical approval will be applied to Inst...
Eligibility Criteria
Inclusion
- Male or female aged between 18 and 65 years.
- diagnosed in their medical history as pre-diabetic patient with fasting plasma glucose (FPG) between 100 and 125 mg dL-1.
- blood pressure within the normal range (systolic blood pressure ≤ 140 mmHg, diastolic blood pressure ≤ 90 mmHg).
- having no other health complications.
Exclusion
- taking any treatment with either insulin or anti-diabetic drugs.
- taking any other natural health products known to impact blood sugar, or polyphenol absorption (e.g. fish oil).
- having liver, thyroid, or significant gastrointestinal disorders.
- pregnant or lactation
- currently Smoker.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04864860
Start Date
March 1 2021
End Date
December 30 2021
Last Update
August 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
clinical Trial Unit
Riyadh, Saudi Arabia, 11362